Long-term administration of AMD3100, an antagonist of SDF-1/CXCR4 signaling, alters fracture repair

Journal of Orthopaedic Research

Volumn 30, Issue 11, 2012, Pages 1853-1859

  Toupadakis, Chrisoula A ^a   Wong, Alice ^a   Genetos, Damian C ^a   Chung, Dai Jung ^a   Murugesh, Deepa ^b   Anderson, Matthew J ^c   Loots, Gabriela G ^b,d   Christiansen, Blaine A ^c   Kapatkin, Amy S ^a   Yellowley, Clare E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adult derived stem cells; AMD3100; CXCR4; fracture; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; COLLAGEN TYPE 1 APHA 1; COLLAGEN TYPE 2; COLLAGEN TYPE 2 ALPHA 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOCORTIN 5; MAMMALIAN TARGET OF RAPAMYCIN; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CELL DIFFERENTIATION; CELL HOMING; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FRACTURE HEALING; HISTOPATHOLOGY; HYPOXIA; IN SITU HYBRIDIZATION; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BIOMECHANICS; CHEMOKINE CXCL12; FRACTURE HEALING; HETEROCYCLIC COMPOUNDS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; OSTEOGENESIS; POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; X-RAY MICROTOMOGRAPHY;

EID: 84867233412     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22145     Document Type: Article

References (49)

1. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. 2003. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88: 873-884.
2. Colnot C, Huang S, Helms J., 2006. Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 350: 557-561.
3. Taguchi K, Ogawa R, Migita M, et al. 2005. The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochem Biophys Res Commun 331: 31-36.
4. Colnot C., 2009. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 24: 274-282.
5. Crisan M, Chen CW, Corselli M, et al. 2009. Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci 1176: 118-123.
6. Otsuru S, Tamai K, Yamazaki T, et al. 2008. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 26: 223-234.
7. Khosla S, Eghbali-Fatourechi GZ., 2006. Circulating cells with osteogenic potential. Ann N Y Acad Sci 1068: 489-497.
8. Kumagai K, Vasanji A, Drazba JA, et al. 2008. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26: 165-175.
9. Dimitriou R, Tsiridis E, Giannoudis PV., 2005. Current concepts of molecular aspects of bone healing. Injury 36: 1392-1404.
10. Brighton CT, Krebs AG., 1972. Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am 54: 323-332.
11. Raheja LF, Genetos DC, Yellowley CE., 2010. The effect of oxygen tension on the long-term osteogenic differentiation and MMP/TIMP expression of human mesenchymal stem cells. Cells Tissues Organs 191: 175-184.
12. Genetos DC, Toupadakis CA, Raheja LF, et al. 2010. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J Cell Biochem 110: 457-467.
13. Semenza GL., 2000. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88: 1474-1480.
14. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
15. Kucia M, Reca R, Miekus K, et al. 2005. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23: 879-894.
16. Rossi D, Zlotnik A., 2000. The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242.
17. Kucia M, Wojakowski W, Reca R, et al. 2006. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an SDF-1-, HGF-, and LIF-dependent manner. Arch Immunol Ther Exp (Warsz) 54: 121-135.
18. Hosogane N, Huang Z, Rawlins BA, et al. 2010. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol 42: 1132-1141.
19. Wright LM, Maloney W, Yu X, et al. 2005. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 36: 840-853.
20. De Falco E, Porcelli D, Torella AR, et al. 2004. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482.
21. Wei L, Kanbe K, Lee M, et al. 2010. Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 341: 236-245.
22. Zhu W, Liang G, Huang Z, et al. 2011. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem 286: 26794-26805.
23. Askari AT, Unzek S, Popovic ZB, et al. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362: 697-703.
24. Hatse S, Princen K, Bridger G, et al. 2002. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527: 255-262.
25. Du R, Lu KV, Petritsch C, et al. 2008. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13: 206-220.
26. Smith MC, Luker KE, Garbow JR, et al. 2004. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612.
27. Rubin JB, Kung AL, Klein RS, et al. 2003. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100: 13513-13518.
28. Bonnarens F, Einhorn TA., 1984. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2: 97-101.
29. Manigrasso MB, O'Connor JP., 2004. Characterization of a closed femur fracture model in mice. J Orthop Trauma 18: 687-695.
30. Marturano JE, Cleveland BC, Byrne MA, et al. 2008. An improved murine femur fracture device for bone healing studies. J Biomech 41: 1222-1228.
31. Gerstenfeld LC, Wronski TJ, Hollinger JO, et al. 2005. Application of histomorphometric methods to the study of bone repair. J Bone Miner Res 20: 1715-1722.
32. Howard C, Reed MG., 2005. Unbiased stereology. New York: Garland Science/BIOS Scientific Publishers.
33. Morgan EF, Mason ZD, Chien KB, et al. 2009. Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function. Bone 44: 335-344.
34. Schmittgen TD, Livak KJ., 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
35. Aro H, Eerola E, Aho AJ, et al. 1984. Tissue oxygen tension in externally stabilized tibial fractures in rabbits during normal healing and infection. J Surg Res 37: 202-207.
36. Epari DR, Lienau J, Schell H, et al. 2008. Pressure, oxygen tension and temperature in the periosteal callus during bone healinga-an in vivo study in sheep. Bone 43: 734-739.
37. Lu C, Rollins M, Hou H, et al. 2008. Tibial fracture decreases oxygen levels at the site of injury. Iowa Orthop J 28: 14-21.
38. Bassett CA, Herrmann I., 1961. Influence of oxygen concentration and mechanical factors on differentiation of connective tissues in vitro. Nature 190: 460-461.
39. Schipani E, Ryan HE, Didrickson S, et al. 2001. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865-2876.
40. Kitaori T, Ito H, Schwarz EM, et al. 2009. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60: 813-823.
41. Granero-Molto F, Weis JA, Miga MI, et al. 2009. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27: 1887-1898.
42. Kim HJ, Kirsch T., 2008. Collagen/annexin V interactions regulate chondrocyte mineralization. J Biol Chem 283: 10310-10317.
43. Wang H, Li X, Tomin E, et al. 2005. Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis. J Orthop Res 23: 671-679.
44. Watanuki M, Sakai A, Sakata T, et al. 2002. Role of inducible nitric oxide synthase in skeletal adaptation to acute increases in mechanical loading. J Bone Miner Res 17: 1015-1025.
45. Diwan AD, Wang MX, Jang D, et al. 2000. Nitric oxide modulates fracture healing. J Bone Miner Res 15: 342-351.
46. Baldik Y, Diwan AD, Appleyard RC, et al. 2005. Deletion of iNOS gene impairs mouse fracture healing. Bone 37: 32-36.
47. Singha UK, Jiang Y, Yu S, et al. 2008. Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem 103: 434-446.
48. Phornphutkul C, Wu KY, Auyeung V, et al. 2008. mTOR signaling contributes to chondrocyte differentiation. Dev Dyn 237: 702-712.
49. Glantschnig H, Fisher JE, Wesolowski G, et al. 2003. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 10: 1165-1177.